Skip to content
healthcare.dev

HYDRALAZINE HYDROCHLORIDE

NDC 72241-004, hydralazine hydrochloride, tablet, from Modavar Pharmaceuticals LLC.

Product NDC
72241-004
Status
Listed
Labeler
Modavar Pharmaceuticals LLC
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA203845
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/72241-004 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • HYDRALAZINE HYDROCHLORIDE25 mg/1

Pharmacologic classes

Arteriolar Vasodilation [PE]; Arteriolar Vasodilator [EPC]

Package NDCNDC-11Package
72241-004-0572241000405100 TABLET in 1 BOTTLE (72241-004-05)
72241-004-11722410004111000 TABLET in 1 BOTTLE (72241-004-11)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/a456bc34-0c79-44f4-9119-50028a978f5f
  • NADAC price for package 72241000411

    GET /v1/drugs/nadac/72241000411

Use it

Look up 72241-004 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/72241-004 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 72241-004. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.